Back to Search
RICHARD SEEGER, M.D.
M.D.
Ophthalmology Physician
NPI: 1083681001IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
150507(NY)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
ALBANY MEDICAL COLLEGE OF UNION UNIVERSITY
Class of 1981
Research & Publications (20)
Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells.
PMID 19118018·Cancer Res·2009
7-preclinical
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.
PMID 19412175·Nat Genet·2009
8-other
Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group.
PMID 19047298·J Clin Oncol·2009
3-trial
ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome.
PMID 19345331·Cancer Cell·2009
8-other
Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages.
PMID 19411762·J Clin Invest·2009
7-preclinical
Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.
PMID 19171716·J Clin Oncol·2009
4-observational
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.
PMID 18937318·Pediatr Blood Cancer·2009
3-trial
Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force.
PMID 19401690·Br J Cancer·2009
4-observational
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.
PMID 19530234·Pediatr Blood Cancer·2009
8-other
Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.
PMID 18463370·N Engl J Med·2008
8-other
Cdc6 knockdown inhibits human neuroblastoma cell proliferation.
PMID 18259842·Mol Cell Biochem·2008
8-other
Molecular characterization of the pediatric preclinical testing panel.
PMID 18628472·Clin Cancer Res·2008
7-preclinical
An integrated cross-platform prognosis study on neuroblastoma patients.
PMID 18598751·Genomics·2008
8-other
Sparse representation and Bayesian detection of genome copy number alterations from microarray data.
PMID 18203770·Bioinformatics·2008
8-other
Shear-induced intracellular loading of cells with molecules by controlled microfluidics.
PMID 17879304·Biotechnol Bioeng·2008
8-other
Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma.
PMID 17710228·J Clin Invest·2007
7-preclinical
De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene.
PMID 17947461·Clin Cancer Res·2007
7-preclinical
The MYCN enigma: significance of MYCN expression in neuroblastoma.
PMID 16510605·Cancer Res·2006
8-other
A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group.
PMID 16551859·Clin Cancer Res·2006
3-trial
Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification.
PMID 16954472·J Natl Cancer Inst·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1015 RIDGE RD
WEBSTER, NY 14580 - Phone
- (585) 872-1300
Quick Facts
- NPI
- 1083681001
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 45
- Publications
- 20
Are you this provider?
Claim Your Profile